News & Events

Our news posts are an easy way to keep up-to-date with all our latest developments. View the event posts to stay informed of all our upcoming events and activities.

Cellectricon and Fluicell initate collaboration to validate tissue-based in vitro models

We’re excited to be working with Fluicell AB and support their development of bioprinted tissues for use in research and...

Cellectricon launches Neuroinflammation Research Service

MÖLNDAL, SWEDEN Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, has launched the Neuroinflammation Research Service module. Established...

Dr. Jonathan Levenson joins Cellectricon’s advisory board

Cellectricon has appointed Dr. Jonathan Levenson, Chief Scientific Officer at FireCyte Therapeutics, to its Scientific Advisory Board. Dr. Levenson brings...

Sign up to get news & events updates from Cellectricon

Cellectricon’s expertise in pain research recognized by second EU research grant

MÖLNDAL, SWEDEN Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, has received follow-on funding for bone pain research...

Senior Scientist, high content imaging and analysis

Cellectricon is an innovative discovery services provider with a focus on the neurobiology of peripheral and central nervous system diseases....

New publication: A Microfluidic High-Capacity Screening Platform for Neurological Disorders

We are happy to announce the publication of “A Microfluidic High-Capacity Screening Platform for Neurological Disorders”. In the paper, published...

Sign up to get news & events updates from Cellectricon

Cellectricon is looking for a scientist to join our team

Cellectricon is an innovative services provider dedicated to advancing drug discovery and research in the areas of peripheral neuropathies, neuroplasticity...

Cellectricon receives CIR (French Research Tax Credit) accreditation

MÖLNDAL, SWEDEN Cellectricon AB, a services provider dedicated to advancing neuroscience drug discovery, today announced that it has received CIR...

Cellectricon expands neuroscience contract research portfolio with new Neuroplasticity services

Mölndal, Sweden Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, today announced the launch of a new service...